Apellis Pharmaceuticals APLS announced that the FDA has accepted its supplemental new drug application (sNDA) seeking the ...

The Alabama Public Library Service (APLS) voted to pause $40,000 in funding to the Fairhope Public Library after the ...

State officials' apparent contradictory statements leave Fairhope officials searching for answers about sudden loss of ...

Scotiabank analyst Greg Harrison maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a price target of ...

Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has accepted and granted Priority Review designation ...

Wahl provided a federal definition of "sexually explicit conduct" that doesn't appear to apply to written content.

They also criticized the Alabama Public Library Services (APLS) board and its chairman, John Wahl, for stating in February ...

In trading on Monday, shares of Apellis Pharmaceuticals Inc (Symbol: APLS) entered into oversold territory, hitting an RSI reading of 26.7, after changing hands as low as $21.89 per share.

Apellis' Empaveli receives FDA Priority Review for rare kidney diseases C3G and IC-MPGN. Phase 3 data show strong efficacy in proteinuria reduction.

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) has received an average recommendation of “Moderate Buy” from ...

Investors in Apellis Pharmaceuticals Inc (Symbol: APLS) saw new options begin trading this week, for the May 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

The National Population Commission (NPC) has called for increased collaboration among stakeholders to tackle Nigeria’s ...